Taiwan launches genetic map for bile duct cancer
NCT ID NCT05036486
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study collects tumor tissue from 480 people with advanced biliary tract cancer in Taiwan to analyze their genetic makeup. The goal is to create a detailed map of genetic changes in this cancer, which could help identify potential targeted therapies. Participants are already receiving or about to start their first standard treatment, and the study simply observes and records their genetic and clinical data.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could create a detailed genetic map of biliary tract cancer in Taiwan, helping doctors match patients with targeted treatments in the future.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly benefit participants and may not lead to new therapies for years, if at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER (BTC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital, Chiayi
Chiayi City, Taiwan
-
China Medical University Hospital
Taichung, Taiwan
-
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital,
Kaohsiung City, Taiwan
-
Koo Foundation Sun Yat-Sen Cancer Center
Taipei, Taiwan
-
Linko Chang Gung Memorial Hospital
Taoyuan, Taiwan
-
MacKay Memorial Hospital
Taipei, Taiwan
-
National Cheng Kung University Hospital
Tainan, Taiwan
-
National Taiwan University Hospital
Taipei, Taiwan
-
Taipei Medical University-Shuang Ho Hospital
Taipei, Taiwan
-
Taipei Veterans General Hospital
Taipei, Taiwan
-
Taoyuan General Hospital, Ministry of Health and Welfare
Taoyuan, Taiwan
-
Tri-Service General Hospital
Taipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Can matching cancer drugs to tumor genes prevent biliary tract cancer return?
- Can a smart drug home in on Hard-to-Treat GI cancers?
- Can a dual immune booster plus chemo shrink hard-to-treat bile duct tumors?
- Can freezing tumors boost immunotherapy in hard-to-treat bile duct cancers?
- New hope for bile duct cancer: drug duo targets tough tumors